Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
Definitive Healthcare Analyst Ratings
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating
Barclays Keeps Their Hold Rating on Definitive Healthcare Corp (DH)
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Avadel Pharmaceuticals (AVDL)
Definitive Healthcare Analyst Ratings
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $8
Stifel Adjusts Price Target on Definitive Healthcare to $9.50 From $11, Maintains Buy Rating
Stifel Maintains Buy on Definitive Healthcare, Lowers Price Target to $9.5
Hold Rating on Definitive Healthcare Corp Amid Q1 Performance and Forecast Revision
Maintaining Hold: Balancing Stability and Uncertainty in Definitive Healthcare Corp's Outlook
Morgan Stanley Downgrades Definitive Healthcare to Equalweight From Overweight, Cuts Price Target to $9 From $11.50
Definitive Healthcare Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Definitive Healthcare Corp (DH), Orthofix (OFIX) and Pharming Group (OtherPHGUF)
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
What 4 Analyst Ratings Have To Say About Definitive Healthcare
Barclays Keeps Their Hold Rating on Definitive Healthcare Corp (DH)
Hold Rating on Definitive Healthcare Amid Leadership Changes and Revenue Uncertainties
Definitive Healthcare Analyst Ratings
Maintaining Hold on Definitive Healthcare Corp Amidst Transition and Mixed Growth Signals